Spleen What It Does And Its Critical Functions

Published

Table of Contents

The spleen, an often-overlooked yet indispensable organ, serves as the body’s silent sentinel in immune defense, blood filtration, and metabolic recycling. Positioned beneath the diaphragm and adjacent to the stomach, this highly vascular structure plays a dual role as both a blood reservoir and a specialized lymphoid tissue. Its intricate anatomy—comprising white pulp for immune surveillance and red pulp for erythrocyte processing—highlights its multifunctional design, bridging hematological and immunological pathways with precision.

Beyond its structural complexity, the spleen’s physiological contributions extend to pathogen elimination, iron conservation, and adaptive immunity, making it a cornerstone of vertebrate survival. From its evolutionary origins in early vertebrates to its clinical relevance in modern medicine, the spleen exemplifies nature’s efficiency in balancing defense and resource optimization. This exploration delves into its anatomical intricacies, physiological mechanisms, and broader implications in health and disease, uncovering why its removal disrupts critical bodily functions.

spleen what it does

Anatomical Overview of the Spleen

The spleen is a secondary lymphoid organ situated within the upper left quadrant of the abdominal cavity, playing a critical role in immune defense, blood filtration, and hematopoiesis. Its anatomical positioning, size, and internal structure reflect its multifunctional nature, distinguishing it from other lymphoid organs such as the thymus or liver. Understanding its precise location, morphology, and histological organization is essential for appreciating its physiological contributions.

The spleen is an oval-shaped, soft, and highly vascular organ typically measuring 12–15 cm in length, 7–8 cm in width, and 3–4 cm in thickness, with an average weight of 150–200 grams in adults. It is located in the left hypochondrium, posterior and lateral to the stomach, inferior to the diaphragm, and adjacent to the left kidney (10th–12th ribs). The spleen is partially protected by the 9th–11th ribs, anchoring it to surrounding structures via the splenorenal ligament, which connects it to the posterior abdominal wall and the gastrosplenic ligament, linking it to the greater curvature of the stomach. Its retroperitoneal position and mobility within the abdominal cavity allow it to adapt to changes in organ volume, such as those occurring during digestion or respiration.

Location and Topographical Relationships

The spleen’s anatomical positioning is influenced by its developmental origin from the mesoderm and its embryonic migration along the dorsal mesentery. In adults, it lies in close proximity to several critical organs, influencing its clinical assessment and potential pathologies:

- Stomach: The spleen is directly adjacent to the greater curvature of the stomach, separated by the gastrosplenic ligament, which contains the short gastric arteries and left gastroepiploic vessels.

  • Diaphragm: The left dome of the diaphragm forms the superior boundary, with the spleen resting on the 9th–11th ribs, which provide partial protection against trauma.
  • Left Kidney: The spleen is positioned anterior and slightly medial to the left kidney, separated by the perirenal fat and splenorenal ligament, which contains the splenic vessels and tail of the pancreas.
  • Tail of the Pancreas: The pancreatic tail lies in close contact with the spleen’s hilum, where the splenic artery and vein enter and exit.
  • Colon: The splenic flexure of the colon is situated inferiorly, contributing to the spleen’s mobility during peristalsis.

    • The spleen’s hilum (a concave indentation) serves as the entry and exit point for the splenic artery, splenic vein, lymphatic vessels, and nerves, facilitating its dual role in blood filtration and immune surveillance.

    Macroscopic Structure and Fibrous Framework

    The spleen’s structural integrity is maintained by a dense fibrous capsule composed of collagen and elastic fibers, which extends inward as trabeculae—thickened connective tissue septa that partition the organ into pulp regions. This fibrous network not only provides mechanical support but also regulates intra-splenic blood pressure and directs blood flow through the organ’s vascular channels.

    Key components of the spleen’s fibrous framework include:

  • Capsule: A 0.5–1 mm thick layer of dense irregular connective tissue, rich in smooth muscle cells, which contracts in response to splenic nerve stimulation, aiding in blood expulsion during physical exertion (e.g., exercise-induced splenic contraction).
  • Trabeculae: Extensions of the capsule that penetrate the parenchyma, dividing the spleen into incomplete lobules. These trabeculae contain branches of the splenic artery and lymphatic vessels, ensuring vascular and lymphatic drainage.
  • Splenic Sinusoids: The trabecular branches give rise to central arteries, which further branch into penicillar arteries and eventually into splenic sinusoids—wide, discontinuous capillaries lined by endothelial cells and reticular fibers, facilitating blood filtration and immune cell interaction.

    • The capsule’s contractile properties are particularly relevant during splenic autotransfusion, where sympathetic stimulation reduces splenic volume by 30–50%, releasing stored blood into circulation—a mechanism critical in maintaining blood pressure during hemorrhage or physical stress.

    Histological Organization: White Pulp and Red Pulp

    The spleen’s internal architecture is divided into two functionally distinct regions: the white pulp (lymphoid tissue) and the red pulp (vascular tissue), each specialized for immune surveillance and blood processing.

    #### White Pulp: Immune Surveillance and Lymphocyte Proliferation
    The white pulp constitutes 20–25% of the spleen’s volume and is organized around branches of the splenic artery, forming periarteriolar lymphoid sheaths (PALS). It consists of:

  • Central Artery (A. centralis): The core of the white pulp, surrounded by T lymphocytes (primarily CD4+ and CD8+ cells).
  • Marginal Zone: A lymphoid-rich area between the white pulp and red pulp, containing B lymphocytes, macrophages, and dendritic cells, critical for antigen trapping and presentation.
  • Lymphoid Follicles (B-cell zones): Germinal centers where B-cell proliferation, class switching, and affinity maturation occur in response to antigens.

    • The white pulp’s highly vascularized structure ensures rapid exposure of lymphocytes to bloodborne pathogens, enabling swift immune responses. Dendritic cells in the marginal zone capture antigens and migrate to T-cell zones or follicles, initiating adaptive immunity.

    #### Red Pulp: Blood Filtration and Erythrocyte Processing
    The red pulp accounts for 75–80% of splenic volume and is composed of:

  • Splenic Sinusoids: Discontinuous capillaries lined by endothelial cells and reticular fibers, allowing extravasation of blood cells and plasma into the splenic cords (Billroth’s cords).
  • Splenic Cords (Cordial Tissue): Loose connective tissue containing macrophages, plasma cells, and erythrocytes, where old or damaged red blood cells (RBCs) are phagocytosed by splenic macrophages.
  • Marginal Sinusoids: Located at the white pulp-red pulp interface, these sinusoids collect filtered blood before it drains into the splenic vein.

    • The red pulp’s open circulation system (unlike the liver’s closed sinusoids) allows direct interaction between blood and immune cells, facilitating:

  • Erythrocyte destruction (via hemoglobin breakdown into bilirubin and iron recycling).
  • Platelet storage and sequestration (up to 30% of the body’s platelets are stored in the spleen).
  • Clearance of encapsulated bacteria (e.g., Streptococcus pneumoniae) via antibody-opsonized phagocytosis.

    • Comparative Anatomy: Spleen vs. Liver vs. Thymus

    The following table contrasts the structural and functional characteristics of the spleen, liver, and thymus, highlighting their unique adaptations to immune and metabolic roles.
    FeatureSpleenLiverThymus
    Primary FunctionImmune surveillance, blood filtration, erythrocyte destruction, platelet storage.Detoxification, bile production, metabolism, immune regulation.T-cell maturation and central tolerance.
    LocationLeft hypochondrium, posterior to stomach, adjacent to left kidney.Right hypochondrium, divided into right and left lobes.Mediastinum, anterior to heart, extends into neck (in children).
    Blood SupplySplenic artery (branch of celiac trunk) → hilum → trabecular arteries.Hepatic artery (celiac trunk) + portal vein (70% blood supply).Internal thoracic arteries (inferior thyroid arteries in fetus).
    Histological RegionsWhite pulp (lymphoid) + red pulp (vascular).Hepatic lobules (central vein, portal triad: bile duct, artery, vein).Cortex (immature T-cells) + medulla (mature T-cells).
    Key Cellular ComponentsWhite pulp: T/B lymphocytes, macrophages, dendritic cells.Kupffer cells (macrophages), hepatocytes, stellate cells.Thymocytes (T-cells), epithelial cells (cortical/medullary).
    Fibrous FrameworkCapsule + trabeculae (collagen/elastic fibers).Glisson’s capsule

    Physiological Functions of the Spleen

    The spleen serves as a critical organ in both immune defense and hematological regulation, functioning as a dynamic filter for blood-borne pathogens, senescent cells, and particulate debris. Its physiological roles extend beyond immune surveillance to include erythrocyte recycling, iron homeostasis, and adaptive immune responses, positioning it as a multifunctional mediator between innate and acquired immunity. The following sections detail its mechanisms in pathogen clearance, cellular recycling, and immune modulation, emphasizing its dual contributions to humoral and cell-mediated immunity.

    Immune Surveillance and Pathogen Clearance

    The spleen acts as a primary lymphoid organ dedicated to filtering circulating blood, removing pathogens, and initiating immune responses. Its white pulp—comprising periarteriolar lymphoid sheaths (PALS) and marginal zones—facilitates antigen presentation and lymphocyte activation, while the red pulp traps and phagocytoses microbes and abnormal cells. The marginal zone, rich in macrophages and dendritic cells, captures blood-borne antigens (e.g., bacteria, viruses, and parasites) and activates B cells for antibody production. Additionally, the spleen detects and sequesters cancerous cells (e.g., leukemic blasts) and encapsulated bacteria (e.g., Streptococcus pneumoniae), preventing systemic dissemination.

    The process begins with blood entering the spleen via the splenic artery, which branches into trabecular arteries and penetrates the white pulp. Antigens in the blood are recognized by marginal zone macrophages and dendritic cells, which then migrate to the PALS to activate T cells or to germinal centers to stimulate B cells. Simultaneously, the red pulp’s cords and sinuses trap pathogens and aged erythrocytes, where fixed macrophages (e.g., red pulp macrophages) phagocytose them. This dual mechanism ensures both immediate pathogen clearance and adaptive immune priming.

    Recycling of Hemoglobin and Iron Homeostasis

    The spleen plays a pivotal role in erythrocyte turnover, recycling hemoglobin from senescent red blood cells (RBCs) to recover iron and generate bilirubin for bile synthesis. This process involves sequential enzymatic degradation and metabolic conversion, ensuring efficient iron reuse and preventing toxic heme accumulation. The following steps outline the biochemical pathway:

    1. Phagocytosis of Aged Erythrocytes
    Red pulp macrophages engulf RBCs with reduced deformability or membrane damage, recognizing them via surface markers (e.g., phosphatidylserine exposure). This occurs primarily in the splenic cords, where macrophages extend pseudopodia to internalize the cells.

    2. Hemoglobin Degradation
    Inside macrophages, hemoglobin is broken down into heme and globin. Globin chains are hydrolyzed into amino acids, while heme undergoes oxidative cleavage by heme oxygenase (HO-1), producing:

  • Bilirubin (via biliverdin reduction by biliverdin reductase),
  • Iron (Fe²⁺) (released for reuse),
  • Carbon monoxide (CO) (a gaseous signaling molecule with vasodilatory effects).

    • 3. Iron Recycling and Storage
    The released iron is bound by ferritin or transferred to transferrin for transport to bone marrow erythroid precursors or storage in hepatocytes. This recirculation prevents iron deficiency anemia and maintains systemic iron homeostasis.

    4. Bilirubin Transport and Excretion
    Bilirubin is conjugated in the liver to bilirubin diglucuronide, excreted into bile, and eventually eliminated via feces. Elevated unconjugated bilirubin (e.g., in splenectomy patients) can lead to jaundice due to impaired clearance.

    Key Enzymatic Reactions:

  • Heme Oxygenase (HO-1): Catalyzes heme → biliverdin + CO + Fe²⁺.
  • Biliverdin Reductase: Converts biliverdin → bilirubin.

    • Erythrocyte Storage and Release vs. Bone Marrow Hematopoiesis

    The spleen functions as a secondary reservoir for erythrocytes, particularly in fetal development and under hypoxic conditions, though its role diminishes postnatally in favor of bone marrow hematopoiesis. The following table compares these processes:
    FeatureSpleen (Erythrocyte Storage)Bone Marrow (Hematopoiesis)
    Primary RoleStorage and release of RBCs during hypoxia or hemorrhage.Production of all blood cells (erythrocytes, leukocytes, platelets).
    MechanismContractile cells (e.g., smooth muscle-like cells in trabecular veins) expel stored RBCs into circulation.Hematopoietic stem cells (HSCs) differentiate into progenitor cells via cytokines (e.g., EPO, GM-CSF).
    RegulationTriggered by sympathetic nervous system or local hypoxia.Regulated by hormonal signals (e.g., erythropoietin from kidneys).
    CapacityStores ~30% of total RBC mass in healthy adults (reduced in splenectomized individuals).Continuous production (~2.5 million RBCs/sec in adults).
    Clinical RelevanceSplenomegaly (e.g., in portal hypertension) impairs storage/release.Bone marrow failure (e.g., aplastic anemia) requires splenic compensation in emergencies.
    In fetal life, the spleen is a major hematopoietic organ, but by adulthood, its erythropoietic function is minimal. However, under extreme stress (e.g., acute blood loss), the spleen can release stored RBCs to maintain oxygen delivery, bridging the gap until bone marrow compensates.

    Dual Role in Humoral and Cell-Mediated Immunity

    The spleen integrates both arms of adaptive immunity, serving as a hub for antigen processing, antibody production, and cytotoxic responses. Its anatomical compartments—white pulp (lymphoid tissue) and red pulp (phagocytic tissue)—enable this dual functionality.
    The spleen’s humoral immunity role involves germinal center reactions in the white pulp, where B cells undergo affinity maturation and class switching to produce high-affinity antibodies (e.g., IgG, IgM) against blood-borne pathogens. Simultaneously, its cell-mediated immunity function relies on macrophage phagocytosis in the red pulp and T-cell activation in the PALS, targeting intracellular pathogens (e.g., Mycobacterium tuberculosis) and cancer cells via cytotoxic T lymphocytes (CTLs).
    Key Processes:
  • Humoral Immunity:
  • Marginal zone B cells capture antigens and present them to T follicular helper (Tfh) cells.
  • Germinal centers generate memory B cells and plasma cells secreting pathogen-specific antibodies.
  • Example: Splenic responses to Haemophilus influenzae involve IgG production to opsonize bacteria for macrophage clearance.

    • - Cell-Mediated Immunity:

  • Dendritic cells in the white pulp cross-present antigens to CD8⁺ T cells, inducing CTL-mediated cytotoxicity.
  • Macrophages in the red pulp phagocytose antibody-opsonized pathogens (e.g., Salmonella typhi).
  • Example: Splenic CD8⁺ T cells eliminate virus-infected hepatocytes during hepatitis B infection.

    • The spleen’s efficiency in these processes is evident in its ability to mount rapid, targeted responses to bloodstream infections, contrasting with lymph nodes, which primarily serve lymphatic drainage.

    spleen what it does - Ilustrasi 2

    Clinical Significance and Disorders of the Spleen

    The spleen, despite its relatively small size, plays a critical role in maintaining immune homeostasis and filtering blood-borne pathogens. Its clinical significance is underscored by a spectrum of disorders—ranging from structural abnormalities like splenomegaly to functional impairments such as hypersplenism—that disrupt its immunologic and hematologic functions. Pathological conditions affecting the spleen often arise from infectious agents, congenital defects, or systemic diseases, each presenting unique diagnostic and therapeutic challenges. Understanding these disorders is essential for clinicians to recognize early signs, implement targeted interventions, and mitigate complications, particularly in high-risk populations such as patients with sickle cell disease or post-splenectomy individuals.

    The spleen’s vulnerability to trauma, its role as a reservoir for blood-borne infections, and its compensatory mechanisms in disease states make it a focal point in both acute and chronic medical management. Below, the discussion explores common splenic disorders, the spleen’s response to infections, surgical interventions, and the heightened susceptibility to encapsulated bacteria in asplenic or functionally asplenic conditions.

    Common Splenic Disorders and Their Mechanisms

    Splenic disorders often manifest through alterations in size, function, or structural integrity, each with distinct etiologies and clinical implications. Splenomegaly, or splenic enlargement, is a non-specific finding observed in conditions such as infectious mononucleosis, portal hypertension (e.g., cirrhosis), hematologic malignancies (e.g., lymphoma), and storage diseases (e.g., Gaucher disease). The underlying mechanisms vary: in infections, splenomegaly results from immune activation and phagocytic overload, while in portal hypertension, it reflects increased blood flow and congestion due to collateral circulation. Splenic rupture, though rare, is a life-threatening complication often associated with trauma (e.g., blunt abdominal injury) or underlying pathology (e.g., mononucleosis-induced splenomegaly). The rupture occurs due to capsule distension exceeding its tensile limits, leading to hemorrhage and potential hypovolemic shock.

    Hypersplenism represents a functional disorder characterized by peripheral cytopenias (anemia, leukopenia, thrombocytopenia) secondary to excessive splenic sequestration and destruction of blood cells. This condition arises in chronic liver diseases, hematologic disorders, or infiltrative processes, where the spleen’s phagocytic activity becomes dysregulated. The clinical presentation includes fatigue, bruising, and recurrent infections, necessitating evaluation of underlying causes and potential splenic intervention.

    Spleen’s Role in Infections: Bacterial and Viral Responses

    The spleen’s immunologic functions are particularly evident in its response to infections, where it acts as a first-line defense against blood-borne pathogens. Bacterial sepsis, particularly from encapsulated organisms such as Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis, exploits the spleen’s role in filtering and opsonizing bacteria. In asplenic or functionally asplenic individuals, the absence of splenic clearance leads to overwhelming bacteremia, a condition known as overwhelming post-splenectomy infection (OPSI). This syndrome is characterized by rapid progression to sepsis, often with high mortality rates, underscoring the spleen’s critical role in controlling encapsulated bacteria.

    In viral infections, the spleen contributes to immune surveillance through its role in T-cell activation and antibody production. For example, during infectious mononucleosis caused by Epstein-Barr virus (EBV), the spleen undergoes reactive hyperplasia due to intense lymphoproliferation, increasing the risk of rupture. Similarly, in malaria, splenic sequestration of parasitized red blood cells leads to splenomegaly and impaired immune function, exacerbating disease severity.

    Surgical Interventions for Splenic Conditions

    When conservative management fails, surgical interventions may be necessary to address splenic disorders. The primary procedures include splenectomy (total removal) and partial splenectomy (resection of a portion), each with distinct indications and risks. Below is a comparative table outlining these interventions:
    Procedure Indications Risks Benefits
    Total Splenectomy
    • Traumatic splenic rupture with hemodynamic instability.
    • Hematologic malignancies (e.g., chronic lymphocytic leukemia with hypersplenism).
    • Hereditary spherocytosis or other hemolytic anemias unresponsive to medical therapy.
    • Infections (e.g., abscesses) refractory to antibiotics.
    • Increased susceptibility to encapsulated bacterial infections (e.g., S. pneumoniae, H. influenzae).
    • Thrombosis risk (e.g., portal vein thrombosis in patients with portal hypertension).
    • Post-splenectomy pain syndrome (chronic left upper quadrant discomfort).
    • Immunologic complications (e.g., autoimmune hemolytic anemia).
    • Resolution of hypersplenism and cytopenias.
    • Definitive treatment for structural defects (e.g., splenic cysts).
    • Reduction in symptomatic splenomegaly.
    Partial Splenectomy
    • Trauma with localized splenic injury (e.g., wedge resection).
    • Select cases of hematologic disorders where partial removal suffices (e.g., certain lymphomas).
    • Preservation of immune function in pediatric or high-risk patients.
    • Higher risk of postoperative bleeding or infection compared to total splenectomy.
    • Potential for recurrent splenomegaly or hypersplenism if insufficient tissue is removed.
    • Retention of partial immune function, reducing infection risks.
    • Lower morbidity compared to total splenectomy.
    • Feasible in patients where splenic preservation is critical (e.g., children).
    Note: Surgical decisions are individualized based on patient comorbidities, underlying pathology, and the urgency of intervention. Non-surgical alternatives, such as splenic artery embolization for trauma, may also be considered to preserve splenic function.

    Asplenia and Susceptibility to Encapsulated Bacteria

    Both congenital asplenia (e.g., in Ivemark syndrome, a rare congenital heart defect) and functional asplenia (e.g., sickle cell disease, where splenic infarction leads to loss of function) confer a significantly elevated risk of severe infections. The spleen’s role in filtering encapsulated bacteria is irreplaceable, as these organisms evade phagocytosis due to their polysaccharide capsules. Without splenic clearance, patients experience overwhelming bacteremia, often with fulminant sepsis and high mortality.

    Key encapsulated pathogens include:

  • Streptococcus pneumoniae (pneumonia, meningitis).
  • Haemophilus influenzae type b (epiglottitis, bacteremia).
  • Neisseria meningitidis (meningococcemia).

    • Preventive strategies for asplenic individuals include:

  • Vaccination: Routine immunization against S. pneumoniae (e.g., PCV13, PPSV23), H. influenzae, and N. meningitidis, with booster doses as recommended.
  • Prophylactic antibiotics: Daily penicillin prophylaxis for high-risk groups (e.g., children with sickle cell disease).
  • Education: Awareness of early signs of infection (e.g., fever, chills, rapid breathing) and prompt medical evaluation.
    • Critical Insight: Asplenic patients should carry an asplenia medical alert card and receive immediate attention for febrile illnesses, as delays in treatment can be fatal.
    The absence of splenic function also predisposes individuals to malaria complications, as the spleen’s role in clearing parasitized red blood cells is lost, leading to severe anemia and organ failure in endemic regions.

    Spleen in Comparative Anatomy and Evolution

    The spleen exhibits remarkable structural and functional diversity across vertebrate lineages, reflecting its adaptive significance in immune defense, hematopoiesis, and metabolic regulation. Evolutionary pressures—such as environmental pathogen exposure, metabolic demands, and circulatory physiology—have shaped splenic morphology and vascular architecture, resulting in variations from jawless fish to mammals. Comparative analysis reveals how the spleen’s role in iron recycling, immune surveillance, and red blood cell (RBC) clearance has been conserved while adapting to aquatic, amphibious, and terrestrial lifestyles. Below, the phylogenetic distribution of splenic traits is examined, alongside the vascular and immunological innovations that underpin its efficiency in different species.

    Phylogenetic Distribution of Splenic Structures and Functions

    The spleen is absent in agnathans (jawless fish, e.g., lampreys and hagfish), which lack adaptive immunity and rely on innate defenses such as lysozyme and natural killer-like cells. In contrast, gnathostomes (jawed vertebrates) possess a spleen, though its structure and function vary significantly between classes. Mammalian spleens are highly specialized for closed vascular circulation, with a white pulp (lymphoid tissue) and red pulp (RBC filtration) separated by marginal zones. Birds and reptiles exhibit a more diffuse splenic architecture, with less distinct white pulp and a reliance on splenic nodules for immune responses. Fish, particularly teleosts (bony fish), demonstrate open splenic circulation, where blood flows freely through sinusoids without a continuous endothelial barrier, facilitating rapid pathogen clearance but increasing susceptibility to systemic infections.
    Key Evolutionary Transition:
    The emergence of the spleen in gnathostomes correlates with the development of adaptive immunity (T and B lymphocytes) and closed circulatory systems, enabling targeted immune responses and efficient RBC recycling.

    Comparative Vascular Architecture and Immune Efficiency

    The spleen’s vascular design directly influences its immunological and hematological functions, particularly in aquatic versus terrestrial environments. Below is a comparison of splenic circulation across major vertebrate groups:
    Vertebrate GroupVascular ArchitectureImplications for Immune EfficiencyExample Species
    Jawless Fish (Agnatha)No spleen; relies on pronephros for immune cell filtrationLack of adaptive immunity; immune responses limited to innate mechanisms (e.g., complement, phagocytes).Lampreys, hagfish
    Cartilaginous Fish (Chondrichthyes)Open circulation with splenic sinusoids lacking endothelial barriersHigh susceptibility to bacterial infections; splenic macrophages clear debris but lack lymphoid organization.Sharks, rays
    Bony Fish (Teleostei)Open circulation with splenic ellipsoids (central arteries surrounded by macrophages)Rapid pathogen clearance but limited adaptive response; splenic nodules form in response to infections.Zebrafish, trout
    AmphibiansIntermediate circulation (partial endothelial lining)Transition toward closed circulation; splenic white pulp emerges but remains less organized than in mammals.Frogs, salamanders
    ReptilesClosed circulation with diffuse white pulpEfficient RBC recycling and immune surveillance; splenic nodules replace distinct germinal centers.Snakes, lizards
    BirdsClosed circulation with well-defined white pulp but no lymph nodesHighly efficient pathogen clearance; splenic B-cell follicles and T-cell zones resemble mammalian structures.Chickens, pigeons
    MammalsClosed circulation with white pulp (periarteriolar lymphoid sheaths) and red pulp (sinusoids)Optimal balance between immune surveillance and RBC turnover; marginal zones act as filters for bloodborne pathogens.Humans, dogs, rodents
    Evolutionary Advantage of Closed Circulation:
    The shift from open to closed splenic circulation in terrestrial vertebrates (amphibians → mammals) reduced blood loss during immune responses and improved targeted lymphocyte activation, enhancing survival in pathogen-rich environments.

    Evolutionary Advantages of the Spleen in Early Vertebrates

    The spleen’s emergence in early gnathostomes provided critical selective advantages, particularly in energy conservation and pathogen defense, which are detailed below:

    Energy Conservation Through Iron Recycling
    The spleen’s role in macrophage-mediated RBC clearance and heme degradation allows for the recovery of iron, a limiting nutrient in aquatic and terrestrial environments. In fish, where hemoglobin turnover is rapid due to low oxygen conditions, splenic macrophages prevent iron loss by recycling it into transferrin-bound iron for erythropoiesis. This mechanism is particularly vital in teleosts, where splenic ellipsoids act as iron sinks, reducing the metabolic cost of synthesizing new hemoglobin.

    Pathogen Defense in Aquatic Environments
    Aquatic vertebrates face unique challenges, including waterborne bacteria, parasites, and fungal infections. The spleen’s open circulation in fish enables rapid macrophage-mediated clearance of bloodborne pathogens without the delays associated with endothelial barriers. Additionally, the splenic ellipsoid system in teleosts acts as a mechanical filter, trapping bacteria and debris while allowing immune cells (e.g., thrombocytes and granulocytes) to initiate inflammatory responses. In contrast, terrestrial vertebrates benefit from closed circulation, which localizes immune reactions to the spleen, preventing systemic spread of infections.

    Adaptive Immunity and Lymphoid Organization
    The development of lymphoid tissue in the spleen of jawed vertebrates marked a pivotal evolutionary step. While agnathans lack lymphocytes, gnathostomes evolved T and B cells, with the spleen serving as a primary site for antigen presentation and clonal selection. In mammals, the white pulp contains periarteriolar lymphoid sheaths (PALS), where T cells interact with dendritic cells, and follicles housing B cells. Birds, lacking lymph nodes, rely entirely on the spleen for humoral and cell-mediated immunity, demonstrating how splenic architecture has been fine-tuned for ecological niches.

    spleen what it does - Ilustrasi 3

    Experimental and Diagnostic Techniques in Splenic Assessment

    The spleen, as a multifunctional lymphoid organ, requires precise diagnostic and experimental techniques to evaluate its structure, function, and pathology. Advanced imaging modalities, biopsy procedures, and laboratory tests are essential for differentiating benign from malignant splenic masses, assessing hematologic disorders, and elucidating splenic physiology. Animal models, particularly genetically modified mice and rats, provide critical insights into splenic development, immune responses, and disease mechanisms, bridging preclinical research with clinical applications.

    Splenic Imaging Modalities and Differentiation of Mass Lesions

    Imaging techniques play a pivotal role in characterizing splenic masses by providing detailed anatomical and functional information. Ultrasound (US) is the first-line, non-invasive modality due to its accessibility, lack of ionizing radiation, and ability to guide interventional procedures. It evaluates splenic size, echotexture, and vascularity, with hypoechoic lesions often suggesting cysts or lymphomas, while hyperechoic masses may indicate granulomas or metastases. Contrast-enhanced ultrasound (CEUS) improves lesion characterization by assessing vascular patterns, where malignant lesions typically exhibit irregular enhancement and washout phases.

    Computed tomography (CT) scans offer superior spatial resolution and are critical for detecting splenic lesions, particularly in trauma or metastatic workup. Non-contrast CT identifies calcifications (e.g., in granulomas), while contrast-enhanced CT (CECT) evaluates lesion vascularity and enhancement patterns. Malignant lesions, such as lymphomas or metastases, often show heterogeneous enhancement with central necrosis, whereas benign lesions like hemangiomas demonstrate peripheral nodular enhancement. Magnetic resonance imaging (MRI) provides superior soft-tissue contrast and functional imaging (e.g., diffusion-weighted imaging, DWI) to differentiate benign from malignant masses. DWI highlights restricted diffusion in high cellularity lesions (e.g., lymphomas), while T2-weighted images may show high signal intensity in cysts or abscesses. Positron emission tomography-CT (PET-CT) integrates metabolic activity with anatomical detail, with FDG-avid lesions suggesting malignancy or inflammation.

    Key Imaging Differentiators:
  • Benign Lesions: Homogeneous enhancement, well-defined borders (e.g., hemangiomas, cysts).
  • Malignant Lesions: Heterogeneous enhancement, irregular borders, restricted diffusion on DWI, FDG avidity.

    • Splenic Biopsy Techniques and Diagnostic Yields

    Biopsy remains the gold standard for definitive diagnosis of splenic pathology, particularly when imaging findings are indeterminate. Fine-needle aspiration (FNA) is a minimally invasive, image-guided procedure (typically under US or CT guidance) that yields cytological samples for hematologic malignancies (e.g., lymphoma, leukemia) or infections (e.g., abscesses). The diagnostic yield of FNA ranges from 70–90% for malignant lesions but may be lower for inflammatory or fibrotic tissues. Complications, including hemorrhage or pneumothorax, occur in <5% of cases, though splenic rupture is rare (<1%).

    Core needle biopsy (CNB) provides histological architecture, improving diagnostic accuracy for granulomatous diseases, infarcts, or metastatic deposits. CNB is performed under US or CT guidance, with larger needles (18–22 gauge) obtaining core samples for immunohistochemical staining. Open splenic biopsy is reserved for complex cases requiring extensive tissue sampling (e.g., diffuse infiltrative diseases) and is associated with higher complication rates (e.g., hemorrhage, infection) but offers the highest diagnostic yield (~95%). Laparoscopic splenic biopsy is an alternative for patients with coagulopathy or high surgical risk, balancing diagnostic accuracy with reduced morbidity.

    Biopsy Indications:
  • Indeterminate splenic masses on imaging.
  • Suspected hematologic malignancy (e.g., lymphoma, myeloproliferative disorders).
  • Unexplained cytopenias with splenomegaly.
  • Evaluation of granulomatous or infectious splenic diseases.

    • Laboratory Tests for Splenic Function and Hematologic Disorders

    Laboratory assessments complement imaging and biopsy by evaluating splenic function, hematologic abnormalities, and systemic involvement. Complete blood count (CBC) with differential identifies cytopenias (e.g., anemia, thrombocytopenia) suggestive of hypersplenism or infiltrative diseases. Peripheral blood smear examines red cell morphology (e.g., schistocytes in microangiopathic hemolytic anemia) and identifies atypical lymphocytes (e.g., in chronic lymphocytic leukemia). Flow cytometry detects immunophenotypic abnormalities in suspected lymphoproliferative disorders, such as CD5+ B-cell lymphomas or hairy cell leukemia.

    Serum protein electrophoresis (SPEP) and immunofixation assess monoclonal gammopathies (e.g., multiple myeloma), while lactate dehydrogenase (LDH) elevations may indicate hemolysis or malignancy. Infectious disease markers (e.g., Epstein-Barr virus [EBV] serology, Mycobacterium tuberculosis PCR) guide diagnosis in splenic abscesses or granulomatous diseases. Bone marrow biopsy is often paired with splenic biopsy in suspected hematologic malignancies to assess systemic involvement. Functional assays, such as splenic uptake scans (e.g., heat-damaged red blood cell scans), evaluate splenic sequestration in conditions like hereditary spherocytosis.

    Critical Laboratory Panels:
  • First-line: CBC, peripheral smear, LDH, SPEP.
  • Hematologic malignancies: Flow cytometry, bone marrow biopsy.
  • Infections/inflammation: EBV/VCA IgM, M. tuberculosis PCR, CRP.
  • Functional assessment: Heat-damaged RBC scan (for hypersplenism).

    • Animal Models in Splenic Physiology and Disease Research

    Animal models are indispensable for studying splenic development, immune responses, and disease pathogenesis, with mice being the most widely used due to genetic tractability and immunological similarity to humans. Splenectomized mice serve as models for post-splenectomy sepsis, immune reconstitution, and red blood cell survival, revealing the spleen’s role in filtering encapsulated bacteria (e.g., Streptococcus pneumoniae). Genetically modified mice (e.g., Itgb2−/− for leukocyte adhesion deficiency, Spl−/− for splenic marginal zone defects) elucidate molecular pathways in immune cell trafficking and splenic architecture.

    Rat models are employed for large-animal studies of splenic trauma, hemorrhage, and regenerative capacity, given their anatomical and physiological similarities to humans. Zebrafish offer optical clarity for real-time imaging of splenic hematopoiesis and immune cell dynamics, while non-human primates provide translational relevance for infectious diseases (e.g., malaria, HIV) and vaccine studies. Conditional knockout models (e.g., Cre-loxP systems) allow tissue-specific ablation of genes (e.g., Sf3b1 in splenic red pulp) to dissect cellular functions. Patient-derived xenografts (PDX) in immunodeficient mice recapitulate human splenic malignancies (e.g., diffuse large B-cell lymphoma) for preclinical drug testing.

    Key Experimental Applications:
  • Immunology: T-cell/B-cell development, marginal zone macrophage function.
  • Infectious disease: Malaria (Plasmodium spp.), sepsis (Listeria monocytogenes).
  • Oncology: Lymphoma engraftment, drug resistance mechanisms.
  • Trauma/regeneration: Splenic infarction models, stem cell mobilization.

    • The spleen’s role as a dynamic regulator of immunity, hematopoiesis, and metabolic recycling underscores its irreplaceable function within the human body. From filtering pathogens and aging red blood cells to recycling iron and modulating immune responses, its contributions are both subtle and profound. Clinical disorders, evolutionary adaptations, and diagnostic techniques further illuminate its significance, revealing a delicate balance between protection and physiological efficiency. Understanding the spleen’s mechanisms not only enhances medical interventions but also deepens appreciation for its evolutionary ingenuity—a testament to nature’s intricate design in sustaining life.

    FAQ

    What does the spleen look like in the human body?

    The spleen is a small, fist-sized organ located in the upper left abdomen, near the stomach and behind the rib cage. It has a soft, spongy texture and a dark reddish-brown color due to its rich blood supply. Its shape is often described as oval or bean-like.

    What does it mean if someone mentions the spleen?

    When someone mentions the spleen, they are typically referring to a vital organ in the immune and circulatory systems. It filters blood, removes old red blood cells, and helps fight infections by storing white blood cells. Problems like enlargement (splenomegaly) or injury can require medical attention.

    What does the spleen produce in the body?

    The spleen does not produce blood cells in adults (unlike in fetuses), but it plays a key role in storing and releasing white blood cells and platelets to help fight infections and control bleeding. It also produces antibodies and helps recycle iron from broken-down red blood cells.

    What does the spleen do in the human body?

    The spleen acts as a filter for blood, removing damaged or old red blood cells, bacteria, and other debris. It also stores immune cells like lymphocytes and macrophages to help the body respond quickly to infections. Additionally, it helps regulate blood volume by releasing stored blood when needed.

    What does the spleen do for the body’s immune system?

    The spleen is a major part of the immune system, acting as a surveillance post for bloodborne pathogens. It traps and destroys bacteria, viruses, and other foreign invaders, while also producing antibodies to target infections. It also removes abnormal or infected blood cells to prevent disease spread.

    What does splenomegaly mean?

    Splenomegaly refers to an enlarged spleen, often caused by infections (like mononucleosis), liver disease, or blood disorders (such as leukemia). Symptoms may include discomfort in the upper left abdomen, feeling full quickly, or bruising easily. Treatment depends on the underlying cause.